Breaking News Instant updates and real-time market news.

PTLA

Portola Pharmaceuticals

$27.36

-0.35 (-1.26%)

07:55
11/14/19
11/14
07:55
11/14/19
07:55

Portola Pharmaceuticals to hold analyst and investor meeting

Analyst & Investor Meeting to be held in New York on November 14 at 8 am. Webcast Link

  • 14

    Nov

  • 07

    Dec

PTLA Portola Pharmaceuticals
$27.36

-0.35 (-1.26%)

08/05/19
FBCO
08/05/19
INITIATION
Target $35
FBCO
Neutral
Portola Pharmaceuticals assumed with a Neutral at Credit Suisse
Credit Suisse analyst Tiago Fauth assumed coverage of Portola Pharmaceuticals with a Neutral rating and $35 price target.
08/05/19
08/05/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Alphatec (ATEC) initiated with an Overweight at Piper Jaffray. 2. So-Young (SY) initiated with a Buy at CLSA. 3. MediWound (MDWD) initiated with a Buy at H.C. Wainwright. 4. Portola Pharmaceuticals (PTLA) assumed with a Neutral at Credit Suisse. 5. Vereit (VER) initiated with an Equal Weight at Morgan Stanley. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
08/08/19
SBSH
08/08/19
NO CHANGE
Target $51
SBSH
Buy
The time to buy Portola Pharmaceuticals is now, says Citi
In a post-earnings research note titled "The Time to Buy is Now," Citi analyst Yigal Nochomovitz raised his price target for Portola Pharmaceuticals to $51 from $50 and keeps a Buy rating on the shares. The analyst continues to believe Andexxa can be a ~$250M product in 2020 and ~$550M by 2022. Getting to half a billion in sales would require one use per month per hospital, assuming "only" ~1500 active hospitals, which is "very achievable," Nochomovitz tells investors in a research note. This means Portola's fair value is ~$50 per share, not the market view of $27 per share, says the analyst.
11/08/19
GSCO
11/08/19
INITIATION
Target $135
GSCO
Neutral
Portola Pharmaceuticals initiated with a Neutral at Goldman Sachs
Goldman Sachs analyst Graig Suvannavejh initiated coverage of Portola Pharmaceuticals with a Neutral rating and $135 price target. The analyst views the shares as fairy valued as "Andexxa launch execution holds the key."

TODAY'S FREE FLY STORIES

HIIQ

Health Insurance Innovations

$19.23

0.88 (4.80%)

13:17
12/12/19
12/12
13:17
12/12/19
13:17
Recommendations
Health Insurance Innovations analyst commentary  »

Health Insurance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
12/12/19
12/12
13:17
12/12/19
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
12/12/19
12/12
13:16
12/12/19
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:08
12/12/19
12/12
13:08
12/12/19
13:08
General news
30-Yr Bond Auction Coupon Rate data reported »

30-Yr Bond Auction Coupon…

13:08
12/12/19
12/12
13:08
12/12/19
13:08
General news
30-Yr Bond Auction Total Amount data reported »

30-Yr Bond Auction Total…

INSG

Inseego

$7.67

0.24 (3.23%)

13:05
12/12/19
12/12
13:05
12/12/19
13:05
Options
Inseego call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRX

Amneal Pharmaceuticals

$5.16

1.675 (48.06%)

13:00
12/12/19
12/12
13:00
12/12/19
13:00
Recommendations
Amneal Pharmaceuticals analyst commentary  »

Amneal Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VRTX

Vertex

$219.47

-0.59 (-0.27%)

, PTI

Proteostasis

$4.01

-0.23 (-5.42%)

12:55
12/12/19
12/12
12:55
12/12/19
12:55
Conference/Events
Cantor Fitzgerald biotech analysts to hold an analyst/industry conference call »

Biotechnology Analysts…

VRTX

Vertex

$219.47

-0.59 (-0.27%)

PTI

Proteostasis

$4.01

-0.23 (-5.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 19

    Mar

ADBE

Adobe

$304.30

0.55 (0.18%)

, AVGO

Broadcom

$324.00

4.14 (1.29%)

12:53
12/12/19
12/12
12:53
12/12/19
12:53
Earnings
Notable companies reporting after market close »

Notable companies…

ADBE

Adobe

$304.30

0.55 (0.18%)

AVGO

Broadcom

$324.00

4.14 (1.29%)

COST

Costco

$295.82

0.6 (0.20%)

ORCL

Oracle

$56.16

-0.15 (-0.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 12

    Dec

  • 12

    Dec

  • 12

    Dec

  • 23

    Jan

12:50
12/12/19
12/12
12:50
12/12/19
12:50
General news
U.S. Household net worth rose »

U.S. Household net worth…

12:50
12/12/19
12/12
12:50
12/12/19
12:50
General news
Treasury Action: yields remain near their highs of the sessio »

Treasury Action: yields…

CC

Chemours

$17.55

0.955 (5.75%)

12:45
12/12/19
12/12
12:45
12/12/19
12:45
Options
Chemours call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:41
12/12/19
12/12
12:41
12/12/19
12:41
Hot Stocks
Breaking Hot Stocks news story  »

Liberty TripAdvisor…

12:36
12/12/19
12/12
12:36
12/12/19
12:36
Hot Stocks
Breaking Hot Stocks news story  »

Liberty TripAdvisor…

PBYI

Puma Biotechnology

$8.89

0.18 (2.07%)

12:32
12/12/19
12/12
12:32
12/12/19
12:32
Hot Stocks
Puma Biotechnology: plasmaMATCH trial shows neratinib activity in ERBB2 cancer »

Puma Biotechnology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOGL

Alphabet Class A

$1,344.42

-0.23 (-0.02%)

, GOOG

Alphabet

$1,346.41

1.27 (0.09%)

12:31
12/12/19
12/12
12:31
12/12/19
12:31
Hot Stocks
Google updates Messages with Verified SMS, spam protection »

Google announced in a…

GOOGL

Alphabet Class A

$1,344.42

-0.23 (-0.02%)

GOOG

Alphabet

$1,346.41

1.27 (0.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GRUB

GrubHub

$41.93

1.7 (4.23%)

12:29
12/12/19
12/12
12:29
12/12/19
12:29
Conference/Events
GrubHub participates in a conference call with Benchmark »

Services/Media Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWTR

Twitter

$30.12

-0.44 (-1.44%)

12:28
12/12/19
12/12
12:28
12/12/19
12:28
Hot Stocks
Twitter to bring back Election Labels for upcoming U.S. election »

Twitter said in a blog…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

GOOGL

Alphabet Class A

$1,344.61

-0.04 (-0.00%)

, GOOG

Alphabet

$1,347.00

1.86 (0.14%)

12:28
12/12/19
12/12
12:28
12/12/19
12:28
On The Fly
Fly Intel: What to watch in Oracle's earnings report »

Oracle (ORCL) is…

GOOGL

Alphabet Class A

$1,344.61

-0.04 (-0.00%)

GOOG

Alphabet

$1,347.00

1.86 (0.14%)

IBM

IBM

$134.98

1.17 (0.87%)

AMZN

Amazon.com

$1,749.62

0.51 (0.03%)

MSFT

Microsoft

$151.85

0.03 (0.02%)

ORCL

Oracle

$56.15

-0.16 (-0.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

BA

Boeing

$346.49

-3.51 (-1.00%)

12:26
12/12/19
12/12
12:26
12/12/19
12:26
Periodicals
Boeing CEO to meet with FAA chief Steve Dickson on Thursday, Reuters reports »

Boeing CEO Dennis…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FOSL

Fossil

$7.72

0.36 (4.89%)

12:25
12/12/19
12/12
12:25
12/12/19
12:25
Options
Fossil Group call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XOM

Exxon Mobil

$69.87

0.92 (1.33%)

, INTC

Intel

$57.44

0.4 (0.70%)

12:25
12/12/19
12/12
12:25
12/12/19
12:25
Conference/Events
Intel to hold a webinar »

Intel Customer Spotlight…

XOM

Exxon Mobil

$69.87

0.92 (1.33%)

INTC

Intel

$57.44

0.4 (0.70%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 23

    Jan

NXGN

NextGen Healthcare

$18.17

0.06 (0.33%)

12:25
12/12/19
12/12
12:25
12/12/19
12:25
Conference/Events
NextGen Healthcare to host analyst day »

Analyst day to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
12/12/19
12/12
12:17
12/12/19
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
12/12/19
12/12
12:16
12/12/19
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.